CellSource Co., Ltd. (JP:4880) has released an update.
Easter Sale - 70% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
CellSource Co., Ltd. has secured a contract with the Tokyo Metropolitan Government to conduct online information sessions for a program subsidizing egg freezing procedures. By offering these sessions, CellSource ensures candidates are well-informed about the process, utilizing their expertise from the ‘Egg Freezing Anshin Bank’ storage service. The company specializes in regenerative medicine and has a distinguished history of over 93,000 cell-related procedures.
For further insights into JP:4880 stock, check out TipRanks’ Stock Analysis page.